PATIENTS with malignant tumours often develop anaemia during some period of their disease. This symptom has been attributed to chronic blood loss or deficiences in dietary intake, but mostly to an incompletely compensated haemolysis. The haemolysis has been ascribed to a shortening of the life span of circulating mature erythrocytes but also of young erythrocytes in the marrow before their release to the blood stream, i.e. ineffective erythropoiesis (Cavallin-St'ahl et al., 1976) . The mechanisms behind the premature cell death are probably many, but the importance of a hyperphagocytic reticuloendothelial system has been stressed by many investigators (Friedel, 1965; Hyman & Hlrvey, 1955; Magarey & Baum, 1970) .
By means of isotope-labelling methods for red cells and the measurement of microsomal haemoxygenase activity responsible for the enzymatic degradation of haemoglobin, it has been found that organs such as spleen, liver and marrow, with capillaries rich in reticuloendothelial cells, are the sites of red-cell destruction (Salky et al., 1967; Schacter et al., 1979) . Erythrophagocytosis has been seen in the marrow of cancer patients and spleens of tumour-bearing animals, using morphological methods (Ponder & Ponder, 1958) .
The deformability of the red cell is a biophysical factor, which determines whether the red cell can traverse capillaries in the microcirculation, often with a smaller diameter than the cell itself. If the cell gets stuck in the fine blood vessels, it causes vascular stasis and may rupture. Such a mechanism has been claimed to be of importance for the haemolysis seen in certain inherited and acquired haemolytic anaemias (Jandl et al., 1961; LaCelle, 1970; Rieber et al., 1977; Usami et al., 1975; Weed, 1975) . The process, resulting in cell destruction, has been defined as a physical one of simple filtration (Jandl et al., 1961) . A decreased deformability of red cells from patients with solid tumours has been described earlier in a preliminary report (Mercke & Cavallin-Stahl, 1978) and also in patients with acute leukaemia (Dintenfass, 1977) . How this pathophysiological mechanism is related to the premature red-cell death as registered in the liver, spleen and marrow in patients with malignant tumours has not, however, been reported on before.
Carbon monoxide, bound to haemoglobin in the blood (COHb) results from breakdown of haeme, yielding molar concentrations of carbon monoxide and bilirubin. Even if COHb level reflects the turnover of all haeme sources (i.e. haemoglobin in circulating erythrocytes and marrow, haeme-containing enzymes of the liver, and myoglobin) it is a good semiquantitative measure of the breakdown of haemoglobin in circulating erythrocytes, since this pool is so much larger than the other pools (Engstedt, 1957) . Reticulocyte count reflects the capacity of the marrow to respond to the demand for new erythrocytes. The present study reports on erythrocyte deformability in a fairly large group of patients with solid tumours, who are compared to a reference group of healthy men. Table. Twenty-five patients, Group A, had anaemia (S-Hb < 115 g/l) and the other half, Group B, had normal serum haemoglobin concentrations (> 115 g/l). Nine healthy nonsmoking men (mean age 24) served as control Group C. All patients considered eligible for the study had their malignant disease diagnosed shortly before the study. Therefore they had not received prior antitumour therapy (i.e. surgery, radiotherapy or chemotherapy) and no such therapy was being given at the time of blood sampling. The only medications allowed were barbiturates and analgesics, but these were withdrawn 48 h before blood sampling. Smokers abstained from smoking for 36 h before. To be accepted for the study no patient should have lost or gained weight during the last month, and they should all be on a normal diet. They were considered to be in steady state haematologically; no patient showed signs of overt bleeding and no blood transfusions had been given. Premenopausal women were excluded from this study, due to known fluctuations in red-cell deformability during the menstrual cycle (Mercke & Lundh, 1976) . All blood samples were collected in the morning around 07:30, with the patients fasting for at least 8 h.
Measurement of erythrocyte deformability.-Erythrocyte deformability (ED) was determined by a method slightly modified from the one described by Miller et al. (1971) .
Ten ml of blood were collected in heparin- ized tubes and washed x 3 in 0155M phosphate buffer (pH 7 4) with a glucose concentration of 5 mm. The cell suspension was left to equilibrate with the buffer for 10 min at 370C. The suspension was then centrifuged at room temperature and the packed erythrocytes were diluted with the buffer to a final haematocrit of 5%. The cell suspension to be filtered was placed in a precalibrated 5ml disposable plastic syringe monitored on a constant-infusion syringe pump with a flow rate of 1-94 ml/min. Polyearbonate sieves (Nucleopore Corporation, Pleasonton, California, U.S.A.) with a mean pore diameter of 5 jtm and a pore density of -3 x O4/cm2 were precut to discs of about 15 mm diameter. The sieve was placed in a specially designed plexiglass filter holder which was connected to the plastic syringe and a pressure transducer. The pressure-time curve was monitored on a Servogor strip chart recorder. The response of the pressure transducer was calibrated with a water-column manometer.
Before each test the filter holder was rinsed with fresh buffer and a control filtration curve with only buffer was recorded. When the syringe was filled with the erythrocyte suspension it was connected to the filter holder. Great care was now taken to avoid the presence of air bubbles, especially inside the filter housing and in the connecting tubes close to the pressure transducer. After the infusion pump was started, erythrocytes in suspension were pushed against the filter and a pressure-time curve for the sample was monitored. All pressure recordings were processed in duplicate, always within 2 h of blood collection. A reference value was obtained from weekly studies during 4 weeks in 9 healthy men. Variation from week to week within the same individual was below 15%. Reproducibility was studied in 30 duplicate analyses from the same material. The coefficient of variation for a single analysis was 12%.
Other analyses.-The CO-contents of the blood samples was measured by gas chromatography as described by Collison et al. (1968) with the modification of Lundh et al. (1975a,b There was a mean rise of AP of 44% during these fevers, with a return to prefever values when the fever subsided spontaneously. In 2 patients, 200 mg/day of indomethacin was given during another fever, with a prompt effect on fever and AP. In these patients AP decreased to levels 34 and 30% below prefever values respectively (Fig. 4) .
DISCUSSION
The deformability of human erythrocytes comprises effects of cell shape, membrane flexibility and fluidity of the intracellular haemoglobin solution (Jandl et al., 1961) . A decrease in deformability predisposes red cells to being trapped and sequestered in the microcirculation, particularly the spleen and liver, in which case cellular haemoglobin is degraded in situ and the clinical picture is "haemolysis". This mechanism of premature cell destruction has been demonstrated for certain anaemias such as sickle-cell anaemia, hereditary sphaerocytosis and acquired auto-immune haemolytic anaemias (Weed 1975; Usami et al., 1975; Jandl et al., 1961; LaCelle, 1970; Rieber et al., 1977) but also during the progesterone phase of the menstrual cycle in healthy women without anaemia (Mercke & Lundh, 1976) . The same mechanism has also been proposed as a determinant of the release of maturing red cells (reticulocytes) from the marrow (Leblond et al., 1971) .
The data in the present study show a significantly low erythrocyte deformability in patients with solid tumours, carcinomas and lymphomas, relative to a control group of healthy men. This increased erythrocyte rigidity was most pronounced in patients with accompanying anaemia. In this latter group, COHb, reflecting the catabolism of erythrocyte haeme, was also AP, cm H20/min higher than in the other patients and the reference group, and there was a strong correlation between this variable and the degree of erythrocyte rigidity. Since none of the patients were on drugs known to be potential liver haeme inducers, and tumour infiltration of the liver was only seen in 2 A A patients in the anaemia group, there is a strong suggestion of a relation between A erythrocyte haemoglobin breakdown and * * decreased deformability of the red cell. The increased erythrocyte catabolism in this group of patients is not followed by reticulocytosis, and anaemia therefore follows. It cannot be deduced from the present investigation whether the in- u -release into the blood stream). As shown in earlier studies in patients with Hodgkin's disease and breast carcinoma, with and without anaemia, survival of circulating red cells, as measured by labelling the patient's own red cells with 51Cr, were normal. The increased CO production found in these studies was therefore attributable to ineffective erythropoiesis, i.e. increased marrow haeme catabolism (Cavallin-Stahl et al., 1976a, b) . The error of the 51Cr-labelling method is large however, especially in the near-normal range. In other studies, red-cell survival has been found to be shorter in cancer patients, both with and without anaemia (Hyman & Harvey, 1955; Ultman, 1958 (Leblond et al., 1971) but were not more frequent in the patient groups than in the control group, and cannot be ascribed to the finding. A few other hypotheses seem valid for discussion. It has been reported that patients with certain malignancies have an increased amount of echinocyte red cells in the circulation (Schwarz, 1949) . Such cells are less deformable as measured with the micropipette technique, when individual cells can be studied (Leblond, 1973) and can also be related to increased haeme turnover (Mercke, 1977) . Many drugs such as anaesthetics (Van Gastel et al., 1973; Seeman, 1972) psychotropic substances (Seeman, 1972) and contrast media (Aspelin, 1979 ) influence red-cell deformability. Also endogenously produced agents such as progesterone, increased in concentration premenstrually (Mercke & Lundh, 1976) and during the last trimester of pregnancy, can alter red-cell deformability (Durocher et al., 1975) . In vitro experiments by Allen & Rasmussen (1971) showed that prostaglandin E2 could drastically decrease erythrocyte deformability. Such small amounts of PGE2 were involved, that the red cell was suggested as a primary target for PGE2 in physiological concentrations. These experiments have later been repeated using another method of determining red-cell deformability. In the present study the highest values of AP (i.e. most deranged deformability) were found in the 4 patients with Hodgkin's disease who developed fever during the course of the investigation and were studied 3 and 4 times respectively. Values returned to prefever level when fever subsided spontaneously, and reached even lower levels after treatment with indomethacin, a prostaglandin-synthetase inhibitor. Since fever in this disease has been attributed to secretion of prostaglandins by tumour tissue, a role for these agents in red-cell deformability may be indicated. Several very recent studies also report increased production of prostaglandins in other solid tumours, both in experimental animals and in man (Bennett et al., 1980; Droller et al., 1979; Fiedler et al., 1979; Trevisani et al., 1980) . Even though stageing is a crude way of deciding tumour burden and the patient material is too small to be analysed in detail, it seems that Group A patients, apart from anaemia, had clinically slightly more advanced disease. The concept of greater PCGE2 production by a larger tumour mass might explain the difference in red-cell haeme turnover between Groups A and B in the present study. But macrophages in the reticulo-endothelial system also have a marked capacity to produce prostaglandins, and PCGE2 in particular (Humes et al., 1977 ) and this capacity is increased when macrophages are stimulated (Morley et al., 1979) . The difference in red-cell haeme turnover between Groups A and B might therefore also reflect a difference in immunological response, compatible with the earlier hypothesis that hyperphagocytosis produces the anaemia in patients with malignant tumours (Friedel, 1965; Hyman & Harvey, 1955; Magarey & Baum, 1970; Salky et al., 1967; Schacter et al., 1979) .
The implications of increased rigidity of erythrocytes in patients with malignancies for the microcirculation (with respect to perfusion, nutrition and oxygenation) of normal and tumour tissue is beyond the scope of the present article. Since it could be a factor of utmost importance for the outcome of both the radiotherapy and chemotherapy of tumours, it is the subject of further exploration in current, ongoing studies in our laboratory.
